A Critical Evaluation of New Agents for the Treatment of Sepsis
Author:
- Roger C. BoneRBRoger C. Bone
- 25 September 1991
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 266 (12) , 1686-1691
Abstract
Research from JAMA — A Critical Evaluation of New Agents for the Treatment of SepsisKeywords
This publication has 15 references indexed in Scilit:
- Sepsis, the Sepsis Syndrome, Multi-Organ Failure: A Plea for Comparable DefinitionsAnnals of Internal Medicine, 1991
- Prophylactic and Therapeutic Effects of a Monoclonal Antibody to Tumor Necrosis Factor- in Experimental Gram-Negative ShockThe Journal of Infectious Diseases, 1990
- Myocardial Dysfunction in Sepsis Recent InsightsChest, 1989
- Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasoneClinical Immunology and Immunopathology, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.Journal of Experimental Medicine, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Sepsis and septic shock—A review of laboratory models and a proposalJournal of Surgical Research, 1980
- Biological Effects of Bacterial Endotoxins in ManThe Journal of Infectious Diseases, 1973